Vimarsana
Biggest News Aggregation in the World

Analog Pharma News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Analog Pharma. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Analog Pharma Today - Breaking & Trending Today

Pheburane® (sodium phenylbutyrate) is now on the Medicaid Preferred Drug List in 10 states - Vimarsana News

Pheburane® (sodium phenylbutyrate) is now on the Medicaid Preferred Drug List in 10 states

/PRNewswire/ - Medunik USA, member of Duchesnay Pharmaceutical Group (DPG) one of the few anchor companies selected by the Government of Canada for its Global...

Pheburane® (sodium phenylbutyrate) coverage to reach ~80% - Vimarsana News

Pheburane® (sodium phenylbutyrate) coverage to reach ~80%

PRINCETON, N.J., Oct. 26, 2023 (GLOBE NEWSWIRE) -- Medunik USA (member of Duchesnay Pharmaceutical Group, an international company selected in the...

Pheburane® (sodium phenylbutyrate) coverage rapidly expands to the benefit of Americans with certain urea cycle disorders (UCDs) - Vimarsana News

Pheburane® (sodium phenylbutyrate) coverage rapidly expands to the benefit of Americans with certain urea cycle disorders (UCDs)

Pheburane® Now on the Preferred Drug List in 6 states and included on the Contract Drug List in California. PRINCETON, N.J., Aug. 09, 2023 (GLOBE NEWSWIRE) -- Medunik USA (member of Duchesnay Pharmaceutical Group) is pleased to announce that an increasing number of Americans with certain urea cycle disorders (UCDs) now have access to Pheburane® (sodium phenylbutyrate) through a rapidly expanding network of key pharmacy benefit managers (PBMs), state Medicaid programs or Managed Medicaid plans. S

Source: yahoo.com
Slynd® (drospirenone) is now covered by the Régie de - Vimarsana News

Slynd® (drospirenone) is now covered by the Régie de

BLAINVILLE, Quebec, July 12, 2023 (GLOBE NEWSWIRE) -- Duchesnay Inc., a pharmaceutical company specializing in women’s health and member of Duchesnay...

Ruzurgi® is Now Available and Covered by the Vast Majority of Public Health and Private Insurance Plans - Vimarsana News

Ruzurgi® is Now Available and Covered by the Vast Majority of Public Health and Private Insurance Plans

Ruzurgi® (amifampridine) BLAINVILLE, Quebec, July 11, 2023 (GLOBE NEWSWIRE) — Médunik Canada, member of Duchesnay Pharmaceutical Group, is pleased to announce…